About InMode

InMode is an Nasdaq listed company focus on developing products and procedures utilising the most innovative radio frequency, light-based energy and laser technologies that strives to enable new emerging minimally-invasive procedures and improve existing surgical procedures. Our minimally invasive and non-invasive procedures are clinically proven to reduce treatment and recovery time.

InMode has leveraged its medically-accepted RF technologies to offer a comprehensive line of platforms that will enable us to capitalise on a multi-billion dollar market opportunity across several categories of surgical specialty such as plastic surgery, gynaecology, dermatology, ENT’s and ophthalmologists.

Our mission is to deliver in our promise! Create innovative technology that leads the industry in enhancing beauty and well-being.

Integrity and excellence in everything we do

Deliver the ultimate customer care and support

Empower employees and customers to grow and thrive

Our Mission

Our mission is to deliver on our promise! Create innovative, life-changing technology that leads the industry in enhancing beauty and well-being.Be Inspired, Be Informed, Be InMode

Our Vision

Develop a culture to inspire, to enjoy and to motivate success for the company, employees, customers and provide cutting-edge procedures that change people’s lives.

Our Values

Integrity and excellence in everything we do. Deliver the ultimate customer care and support. Empower employees and customers to grow and thrive by creating a positive, educational and progressive environment.

Meet Our Leadership Team

Managing Director

Dennis Cronje

Dennis Cronje is the Managing Director for Australia and New Zealand who previously served as Managing Director for Palomar Medical and Cynosure Australia and brings an extensive sales and marketing background to this position. Dennis has been involved in light-based technologies for over 15 years and has had experience in the medical industry since 1987.

He has held senior management and directorship positions in sales and marketing, has a qualification in Advanced Marketing, and is a graduate of the Australian Institute of Company Directors. His passion and commitment to deliver on our promises will guarantee the success of the company and its customers in the ANZ market.

Head of Medical Sales and Marketing

Cherie Yoong

Cherie is Head of Medical Sales & Marketing for InMode Australia & New Zealand, with extensive experience driving growth across the aesthetic, pharmaceutical and medical device sectors. She leads the integration of strategic marketing with high-performance sales execution to support brand expansion and product adoption.

Known for her ability to translate market insight into practical strategy, Cherie has led brand campaigns, educational programs and industry events that strengthen engagement and long-term brand loyalty. Her career is marked by multiple industry recognitions, reflecting a strong blend of commercial acumen, team leadership and strategic execution.

Cherie holds a Bachelor of Science in Business Administration, majoring in Marketing, underpinning her approach to building scalable growth and high-performing teams.

National Sales Manager – Aesthetics

Greg Cox

Greg Cox is a senior sales leader and solutions specialist with over 30 years experience in the technology and managed services industry across Australia. He has led national sales teams, enterprise partnerships and dealership operations, delivering tailored B2B solutions across SMB to enterprise environments.

Greg is known for driving sustainable revenue growth, building high-performing teams and executing effective go-to-market strategies. With a leadership style grounded in integrity, collaboration and commercial insight, he brings a disciplined, people-first approach shaped by both extensive industry experience and a professional AFL background.

Head of Clinical

Tali Hingst

We are delighted to introduce our new Head of Clinical, Tali Hingst who brings more than 31 years of experience in the aesthetics and medical space. With a career spanning clinic management, tertiary education, and over five years of training alongside InMode, she has a deep understanding of both the science and practice of advanced technologies.

Tali brings her expertise in dermatoscopy for skin cancer detection, as well as supporting clinics across Queensland in recent years. Beyond her professional achievements, she is also a Birth Doula, a unique and personal passion that speaks to her commitment to care and support.

Head of Consumables and Regenerative Aesthetics

Patricia Amalm

Patricia Amalm is Head of Consumables & Regenerative at InMode Australia & New Zealand, responsible for the clinical strategy, education, and growth of the consumables and exosomes portfolio. With a strong focus on regenerative aesthetics, Patricia partners with clinics to integrate ASCE+ Exosomes alongside energy-based technologies to enhance patient outcomes and long-term results.

Head of Service

Robbie Zhang

Robbie Zhang is a seasoned Operations and Service Leader with over 18 years of experience across medical devices, technology, and fast-paced commercial environments. He brings a strong blend of technical expertise, strategic thinking, and people leadership, with a proven track record of driving operational excellence and customer satisfaction.

Robbie has extensive experience in service team leadership, territory management, project and product support, troubleshooting, and new product processes, along with a deep understanding of customer and clinical needs. Known for his clear communication style and collaborative approach, he works closely with internal teams, distributors, and customers to deliver reliable solutions and long-term value.

Highly organised, analytical, and goal-oriented, Robbie is passionate about continuous improvement and supporting teams to perform at their best.

Our Journey

Foundations of Innovation

Invasix/InMode companies are launched by Moshe Mizrahy, InMode’s global CEO and Michael Kreindel, CTO, who is a master physicist and is known as one of the founding fathers of IPL technology.

Regulatory Momentum & Technology Validation

InMode receives more than 10 U.S. FDA clearances for new, innovative minimally invasive and non-invasive technologies including, RFAL and IPL-based solutions.

Advancing Minimally Invasive RFAL

InMode receives FDA clearances for its BodyTite RFAL minimally invasive handpieces for electro coagulation and hemostasis.

Global Expansion & Portfolio Growth

InMode triples its distribution team and launches six new proprietary aesthetic solutions that will lead the industry in innovation.

Public Market Milestone

InMode becomes a publicly traded company on NASDAQ under the symbol ‘INMD’ and continues to expand its presence globally.

Morpheus8 Platform Evolution

InMode expands upon the success of Morpheus8 with the launch of the Morpheus8 platform and Morpheus8 Body technology.

Entering Women’s Health

InMode launches EmpowerRF, a multi-functional platform delivering safe and effective women’s wellness therapies.

Record-Breaking Financial Performance

InMode exceeds $450M in revenues, an unprecedented record in the energy-based aesthetic medical device market.

Broadening Clinical Horizons

InMode‘s global footprint spans across 97 countries. The company launches Envision, a precision treatment platform for ophthalmology, and Define, a hybrid platform that redefines in-office facial procedures.

Redefining Soft Tissue Contraction

InMode launches the new IgniteRF platform with QuantumRF, the ultimate solution for soft tissue contraction. Morpheus8 becomes the first and only fractional radiofrequency (FRF) microneedling technology cleared for soft tissue contraction with +2.5M procedures performed worldwide.

Portfolio Expansion & Precision Design

InMode global expands its product portfolio with the launch of Solaria, a fractionated carbon dioxide (CO2) platform and the ApexRF platform with the Apex technology designed specifically for the male anatomy.

Next-Generation Innovation

InMode introduces Picofy and QMode, continuing its trajectory of platform-led innovation.

2008
2011-2016
2016
2017-2018
2019
2020
2021
2022
2023
2024
2025
2026

FOLLOW US on INSTAGRAM

Do you have any questions ?

If you have any questions regarding any of our technologies, treatments or anything in general, we’re here to help! Please do not include any sensitive personal data (such as patient photos or health information) when submitting this form.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.